News at a glance.
Galenica reports strong sales growth once again
Ad hoc announcement pursuant to Art. 53 LR, Thursday, 23 January 2025
Galenica Group sales once again performed very positively in 2024, with growth of 4.7% to CHF 3,922 million. As a result, Galenica outperformed the entire pharmaceutical market in terms of growth (+3.5%, IQVIA, Pharmaceutical Market Switzerland, YTD December 2024).
News at a glance
Here you will find all ad hoc announcements, press releases and news about the Galenica network. Stay up to date and subscribe to our ad hoc announcements and press releases by e-mail.

Latest ad hoc announcements and press releases
All relevant news from the Galenica network in our ad hoc announcements and press releases.


Downloads for media
Images of various business activities from the Galenica network and the Galenica logo for journalistic use.

«We demonstrate how we create added value within the Galenica network; for our customers, employees, investors, partners and Switzerland’s healthcare system.»
Iris Müller, Head of Corporate Communications